Sale!

COG7 Gene Glycosylation Disorder Type 2E Genetic Test

Original price was: $700.Current price is: $500.

-29%

The COG7 Gene Glycosylation Disorder Type 2E NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the COG7 gene responsible for congenital disorders of glycosylation. This specialized test utilizes next-generation sequencing technology to detect genetic abnormalities that disrupt protein glycosylation processes, leading to severe metabolic and developmental complications. Patients experiencing unexplained neurological symptoms, developmental delays, or multi-system organ dysfunction should consider this test for accurate diagnosis. The test provides crucial information for personalized treatment strategies and genetic counseling. Available for $500 USD, this advanced genetic analysis helps families understand inherited metabolic conditions and make informed healthcare decisions.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

COG7 Gene Glycosylation Disorder Type 2E NGS Genetic DNA Test

Comprehensive Genetic Testing for Metabolic Disorders

The COG7 Gene Glycosylation Disorder Type 2E NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying congenital disorders of glycosylation (CDG). This specialized genetic analysis focuses on the COG7 gene, which plays a critical role in the proper functioning of the conserved oligomeric Golgi complex. When mutations occur in this gene, they disrupt essential glycosylation processes, leading to severe metabolic and developmental challenges that affect multiple organ systems.

What This Test Measures and Detects

Our advanced NGS (Next-Generation Sequencing) technology specifically targets and analyzes the COG7 gene to identify pathogenic variants responsible for Glycosylation Disorder Type 2E. The test examines:

  • Complete COG7 gene sequencing for comprehensive mutation detection
  • Point mutations, insertions, and deletions affecting protein function
  • Genetic variations that disrupt Golgi complex assembly and function
  • Inheritance patterns for family genetic counseling
  • Specific biomarkers associated with glycosylation pathway disruptions

Who Should Consider This Genetic Test

This specialized genetic testing is recommended for individuals presenting with symptoms suggestive of congenital disorders of glycosylation, including:

  • Infants and children with unexplained developmental delays
  • Patients with neurological abnormalities including seizures and hypotonia
  • Individuals with multi-system involvement including liver dysfunction
  • Those with abnormal coagulation profiles and bleeding tendencies
  • Patients with distinctive facial features and skeletal abnormalities
  • Families with history of metabolic disorders or unexplained infant mortality

Key Benefits of COG7 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages for patients and healthcare providers:

  • Accurate Diagnosis: Precise identification of COG7 gene mutations enables targeted treatment approaches
  • Early Intervention: Timely detection allows for proactive management of metabolic complications
  • Family Planning: Genetic counseling based on test results supports informed reproductive decisions
  • Personalized Care: Test outcomes guide development of individualized therapeutic strategies
  • Prognostic Information: Understanding genetic variants helps predict disease progression and outcomes

Understanding Your Test Results

Our comprehensive genetic report provides detailed analysis and interpretation of your COG7 gene sequencing results. The report includes:

  • Clear identification of detected genetic variants and their clinical significance
  • Explanation of how specific mutations affect glycosylation processes
  • Guidance on inheritance patterns and family member testing recommendations
  • Correlation between genetic findings and clinical manifestations
  • Recommendations for ongoing monitoring and specialized care requirements

Test Pricing Information

Test Component Price (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We proudly offer COG7 Gene Glycosylation Disorder Type 2E NGS Genetic DNA testing across our extensive network of diagnostic centers throughout the United States. Our facilities are conveniently located in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Each location maintains the highest standards of genetic testing excellence and patient care.

Take Control of Your Genetic Health Today

Don’t let uncertainty about metabolic disorders affect your quality of life. Our specialized COG7 genetic testing provides the clarity needed for effective healthcare planning and management. With results available within 3-4 weeks and multiple sample collection options including blood, extracted DNA, or blood spots on FTA cards, accessing this advanced diagnostic service has never been more convenient.

Ready to schedule your genetic test? Contact our genetic counseling team at +1(267) 388-9828 or book your appointment online to begin your journey toward accurate diagnosis and personalized care.